Andreas Alexopoulos, MD

Appointed
2005

Education & Fellowships

Fellowship - Cleveland Clinic
Intracranial Neurophysiology
Cleveland, OH USA
2005

Fellowship - Cleveland Clinic
Clinical Neurophysiology
Cleveland, OH USA
2003

Residency - Mount Sinai Medical Center
Neurology
New York, NY USA
2002

Internship - Newton-Wellesley Hospital
Internal Medicine
Newton Lower Falls, MA USA
1999

Medical Education - University of Athens Faculty of Medicine, National & Kapodistrian
Athens, Greece
1993

Additional Training

• Consortium of Eastern Ohio Master of Public Health (degree awarded by Cleveland State University)

Professional Highlights

• Dr. Alexopoulos is principal investigator or co-investigator of several research trials. His research has been published in leading peer-reviewed journals, and he has contributed numerous chapters to medical textbooks in his field. He has twice received the Cleveland Clinic’s World Class Service Recognition Award.
  
  Dr. Alexopoulos has been the Director of the clinical and research fellowship programs in epilepsy and clinical neurophysiology at the Cleveland Clinic Epilepsy Center since 2009. Currently, he is also the Director of the Neurological & Behavioral Sciences year 1 course at the Cleveland Clinic College of Medicine of the Case Western Reserve University.
  
  Dr. Alexopoulos is a member of the American Epilepsy Society, the Society of Neuroscience and the American Clinical Neurophysiology Society, among others. He is a Diplomate of neurology and the subspecialty of clinical neurophysiology of the American Board of Psychiatry and Neurology.

Certifications

• Psychiatry and Neurology - Epilepsy
• Psychiatry and Neurology - Neurology
• Psychiatry and Neurology - Clinical Neurophysiology

Specialty Interests

Adult and geriatric epilepsy, seizure manifestations, medical and surgical treatment of seizure disorders, clinical neurophysiology, electroencephalography (EEG), magnetoencephalography (MEG), video-EEG, epilepsy surgery, multimodality non invasive investigations in patients with epilepsy, functional MRI (fMRI), EEG/fMRI, intracranial EEG monitoring for presurgical evaluation, neurostimulation, advancements in noninvasive diagnosis and management of patients with epilepsy

Awards & Honors

• Chief Resident in Neurology, Mount Sinai Medical Center, New York
• Chief Fellow in Epilepsy, Cleveland Clinic
• Excellence in Teaching Award, Mount Sinai Medical Student Council 
• Distinction for Honorary Graduation, University of Athens School of Medicine

Innovations & Patents

• Dr. Alexopoulos has been instrumental in establishing the magnetoencephalography (MEG) laboratory at the Cleveland Clinic Epilepsy Center. The laboratory, which has been in operation since 2009, provides cutting edge recordings and interpretations of clinical MEG signals in patients with difficult-to-treat epilepsies.
  

Memberships

• American Epilepsy Society
• American Clinical Neurophysiology Society
• Society for Neuroscience
• American Academy of Neurology
• Certified Member of the American Society of Neuroimaging

See publications for Andreas Alexopoulos, MD.

(Disclaimer: This search is powered by PubMed, a service of the U.S. National Library of Medicine. PubMed is a third-party website with no affiliation with Cleveland Clinic.)

Cleveland Clinic physicians and scientists may collaborate with the pharmaceutical or medical device industries to help develop medical breakthroughs or provide medical expertise or education. Cleveland Clinic strives to make scientific advances that will benefit patient care and support outside relationships that promise public benefit. In order for the discoveries of Cleveland Clinic physicians' and scientists' laboratories and investigations to benefit the public, these discoveries must be commercialized in partnership with industry. As experts in their fields, Cleveland Clinic physicians and scientists are often sought after by industry to consult, provide expertise and education.

To assure professional and commercial integrity in such matters, Cleveland Clinic maintains a program that reviews these collaborations and, when appropriate, puts measures in place to minimize bias that may result from ties to industry. Cleveland Clinic publicly discloses the names of companies when (i) its physicians/scientists receive $5,000 or more per year (or, in rare cases, equity or stock options) for speaking and consulting, (ii) its physicians/scientists serve as a fiduciary, (iii) its physicians/scientists receive or have the right to receive royalties or (iv) its physicians/ scientists hold any equity interest for the physician's/scientist's role as inventor, discoverer, developer, founder or consultant.* In publicly disclosing this information, Cleveland Clinic tries to provide information as accurately as possible about its physicians' and scientists' connections with industry.

As of 7/31/2023, Dr. Alexopoulos has reported no financial relationship with industry that is applicable to this listing. In general, patients should feel free to contact their doctor about any of the relationships and how the relationships are overseen by Cleveland Clinic. To learn more about Cleveland Clinic's policies on collaborations with industry and innovation management, go to our Integrity in Innovation page.

Public Health Service-Reportable Financial Conflicts of Interest. Cleveland Clinic scientists and physicians engage in basic, translational and clinical research activities, working to solve health problems, enhance patient care and improve quality of life for patients. Interactions with industry are essential to bringing the researchers' discoveries to the public, but can present the potential for conflicts of interest related to their research activities. Click here to view a listing of instances where Cleveland Clinic has identified a Public Health Service (PHS)-Reportable Financial Conflict of Interest and has put measures in place to ensure that, to the extent possible, the design, conduct and reporting of the research is free from bias.

* Cleveland Clinic physicians and scientists subscribe to the guidance presented in the PhRMA Code on Interactions with Healthcare Professionals and the AdvaMed Code of Ethics on Interactions with Health Care Professionals. As such, gifts of substantial value are generally prohibited.